Asthma mixed form (mode), excluding more controls

ASTHMA_MIXED_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %J458 Registry filters: Hospital discharge: ICD-10 — J45.8 Cause of death: ICD-10 — J45.8 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: J10_ASTHMA, ALLERG_ASTHMA, VOCALCORDDYS, I9_HEARTFAIL, J10_HYPERSPNEUMONI, ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_MIXED_EXMORE
CONTROL_EXCLUDE	J10_ASTHMA\|ALLERG_ASTHMA\|VOCALCORDDYS\|I9_HEARTFAIL\|J10_HYPERSPNEUMONI\|ASTHMA_EXCL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%J458
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%J458
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma mixed form (mode), excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Asthma mixed form (mode)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	25457	12665	12623
Only index persons	21583	11039	10544
Unadjusted period prevalence (%)
Whole population	0.36	0.36	0.35
Only index persons	0.40	0.41	0.40
Median age at first event (years)
Whole population	40.31	48.39	31.78
Only index persons	36.53	46.30	26.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2468	1461	1007
Unadjusted period prevalence (%)	0.48	0.50	0.44
Median age at first event (years)	53.62	49.30	59.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2224: Matched controls
22250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03BB04

ATC

tiotropium bromide; inhalant

50.9

323.0

597

159

R03BA02

ATC

budesonide; inhalant

15.5

323.0

923

970

J45.9

ICD-10 Finland

Asthma, unspecified

82.9

323.0

1250

339

R03AK07

ATC

formoterol and budesonide; inhalant

10.9

323.0

860

1218

J45.8

ICD-10 Finland

Mixed asthma

+∞

323.0

2225

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

84.0

323.0

503

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

142.2

323.0

1765

585

R03BA05

ATC

fluticasone; inhalant

16.2

323.0

1032

1130

R96

ICPC

Asthma

22.3

323.0

500

285

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

59.9

323.0

517

112

J18.9

ICD-10 Finland

Pneumonia, unspecified

25.4

323.0

626

338

J45.1

ICD-10 Finland

Nonallergic asthma

182.4

323.0

416

H02AB06

ATC

prednisolone; systemic

10.5

323.0

1619

4498

J45.0

ICD-10 Finland

Predominantly allergic asthma

123.0

323.0

629

R03DC03

ATC

montelukast; oral

19.6

323.0

967

837

R03AK06

ATC

salmeterol and fluticasone; inhalant

30.8

323.0

977

550

R03BA01

ATC

beclometasone; inhalant

15.9

323.0

807

769

R03AC02

ATC

salbutamol; inhalant

33.2

323.0

2033

5374

R03AC12

ATC

salmeterol; inhalant

63.9

323.0

391

R03AC03

ATC

terbutaline; inhalant

10.7

310.9

661

843

R03DA04

ATC

theophylline; systemic, rectal

33.3

290.4

386

139

J45

ICD-10 Finland

Asthma

16.8

273.0

456

336

XG474

NOMESCO Finland

Exhalation nntrogen oxide

97.2

249.0

273

R03AC13

ATC

formoterol; inhalant

37.0

238.1

308

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

302.3

217.5

218

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

7.1

201.3

548

972

UGC12

NOMESCO Finland

Flexible bronchoscopy

28.2

200.5

278

112

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

62.4

197.0

230

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

121.9

196.0

210

R06.0

ICD-10 Finland

Dyspnoea

5.4

192.7

678

1659

R03AK08

ATC

formoterol and beclometasone; inhalant

41.2

192.5

243

R03BA08

ATC

ciclesonide; inhalant

12.2

189.6

363

350

J46

ICD-10 Finland

Status asthmaticus

143.1

174.2

184

R01AD08

ATC

fluticasone; nasal

4.2

165.2

779

2516

I50.9

ICD-10 Finland

Heart failure, unspecified

22.0

161.5

241

122

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

24.5

160.9

232

105

R06AE07

ATC

cetirizine; oral

3.4

157.6

1162

5390

J01AA02

ATC

doxycycline; systemic

3.8

156.6

1789

11552

XG410

NOMESCO Finland

Flow-volume spirometry

33.7

156.1

206

J01FA06

ATC

roxithromycin; oral

3.5

153.2

1032

4438

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

26.8

146.1

205

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

314.1

145.3

146

H02AB04

ATC

methylprednisolone; systemic

5.7

141.0

454

961

R01AD01

ATC

beclometasone; nasal

5.0

138.7

502

1213

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

189.3

137.3

142

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

10.7

134.4

273

288

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

42.1

134.0

168

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

15.0

132.6

228

168

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

346.9

132.0

132

R01AD09

ATC

mometasone; nasal

3.1

131.5

1068

5091

XQ800

NOMESCO Finland

Prick test

9.0

130.4

293

370

R06.2

ICD-10 Finland

Wheezing

16.9

129.4

212

138

I50.0

ICD-10 Finland

Congestive heart failure

74.7

129.4

147

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

125.2

119

49300

ICD-8 Finland

Asthma, bronchiale

+∞

125.2

119

J01MA14

ATC

moxifloxacin; systemic

9.1

120.1

267

329

XG405

NOMESCO Finland

Education on PEF monitoring

82.6

117.7

132

R03BB01

ATC

ipratropium bromide; inhalant

17.2

114.8

186

117

Z01.8

ICD-10 Finland

Other specified special examinations

3.6

110.6

609

2124

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

12.0

110.5

210

192

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.8

105.4

984

4919

C03CA01

ATC

furosemide; systemic

3.4

101.7

595

2155

R03AK11

ATC

formoterol and fluticasone; inhalant

27.9

97.0

134

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

96.4

1132

6363

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

109.0

95.8

104

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.6

93.0

493

1639

J01FA10

ATC

azithromycin; systemic

2.5

91.8

1329

8281

SPAT1059

SPAT

Spirometry at the office

8.8

91.6

206

256

J96.1

ICD-10 Finland

Chronic respiratory failure

+∞

91.3

H02AB07

ATC

prednisone; oral

4.2

90.3

381

1036

J01FA09

ATC

clarithromycin; systemic

2.8

89.0

745

3396

R03DC01

ATC

zafirlukast; oral

38.5

86.3

110

Z71.8

ICD-10 Finland

Other specified counselling

2.9

84.6

648

2776

R03BC03

ATC

nedocromil; inhalant

5.8

84.5

256

486

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.2

84.2

281

598

RD211

NOMESCO Finland

6.9

84.0

221

348

J47

ICD-10 Finland

Bronchiectasis

+∞

83.9

R01AD12

ATC

fluticasone furoate; nasal

2.8

83.3

680

3027

J31.0

ICD-10 Finland

Chronic rhinitis

10.4

82.6

168

174

R02

ICPC

Shortness of breath/dyspnoea

4.9

81.4

289

657

R06AX27

ATC

desloratadine; oral

2.8

80.3

666

2981

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

3.2

78.7

491

1818

TDM10

NOMESCO Finland

Puncture of maxillary antrum

70.3

76.9

J33.0

ICD-10 Finland

Polyp of nasal cavity

73.4

74.8

I50.1

ICD-10 Finland

Left ventricular failure

258.5

73.8

S01GX01

ATC

cromoglicic acid; ophthalmic

3.0

73.6

518

2073

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

73.3

WZC30

NOMESCO Finland

Teaching

3.6

70.5

350

1082

Z00.0

ICD-10 Finland

General medical examination

2.8

69.5

518

2142

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

352.7

68.9

R95

ICPC

Chron obstructive pulmonary disease

30.9

68.7

R06AX13

ATC

loratadine; oral

3.2

67.9

401

1413

J34.2

ICD-10 Finland

Deviated nasal septum

76.6

65.5

R01AD05

ATC

budesonide; nasal

5.1

64.9

217

458

R01AD11

ATC

triamcinolone; nasal

4.5

64.8

250

613

TGC00

NOMESCO Finland

Bronchial lavation

49.7

63.7

SPAT1058

SPAT

PEF monitoring instruction

4.7

63.2

229

527

N02AX02

ATC

tramadol; systemic, rectal

2.2

63.0

857

4853

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.5

62.8

624

3022

J35.0

ICD-10 Finland

Chronic tonsillitis

73.1

62.5

R06AX22

ATC

ebastine; oral

3.0

62.3

418

1603

EMB10

NOMESCO Finland

Tonsillectomy

36.0

62.0

J35.2

ICD-10 Finland

Hypertrophy of adenoids

+∞

61.7

J01CA04

ATC

amoxicillin; systemic

2.3

61.0

1736

13515

A02BC02

ATC

pantoprazole; systemic

2.1

60.7

1281

8737

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

78.0

60.4

R06AE09

ATC

levocetirizine; oral

3.2

60.4

366

1306

UDH02

NOMESCO Finland

Rhinopharyngoscopy

8.7

60.2

134

162

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.6

59.7

293

890

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

27.9

59.0

R06AX26

ATC

fexofenadine; oral

5.0

58.5

201

436

R05

ICD-10 Finland

Cough

2.9

57.8

406

1594

R03BC01

ATC

cromoglicic acid; inhalant

16.7

57.4

RF410

NOMESCO Finland

17.1

57.3

C07AB07

ATC

bisoprolol; oral

2.1

57.2

892

5309

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.3

57.1

651

3351

G47.3

ICD-10 Finland

Sleep apnoea

2.8

56.2

402

1597

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

8.1

55.9

130

169

R01AC01

ATC

cromoglicic acid; nasal

6.6

55.8

150

241

SPAT1252

SPAT

Overall medication plan or its review

4.3

55.4

219

548

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

148.7

55.1

R01BA52

ATC

pseudoephedrine, combinations; oral

2.3

54.9

632

3257

N02BE01

ATC

paracetamol; systemic, rectal

2.2

54.1

1776

14223

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.6

53.7

477

2144

J30.3

ICD-10 Finland

Other allergic rhinitis

10.4

53.7

108

109

J01DA01

ATC

[U] cefalexin; systemic

2.0

53.3

1305

9228

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

52.3

A02BC03

ATC

lansoprazole; oral

2.3

52.0

614

3190

R5140

NOMESCO Finland

Monitoring the use of the aid

3.7

51.6

241

699

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

180.8

51.1

R04.2

ICD-10 Finland

Haemoptysis

12.2

50.9

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.8

50.6

233

668

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

+∞

50.2

A02BC05

ATC

esomeprazole; systemic

2.1

50.1

793

4676

RF420

NOMESCO Finland

13.2

50.0

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

9.0

48.8

106

123

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

48.2

719

4119

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

47.7

893

5606

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

23.3

47.2

J01FA15

ATC

telithromycin; oral

3.5

46.0

228

693

M54.5

ICD-10 Finland

Low back pain

2.1

45.6

657

3692

J01MA12

ATC

levofloxacin; systemic

2.8

45.3

334

1337

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.5

44.6

398

1775

C01CA24

ATC

epinephrine; parenteral

4.4

44.6

172

418

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

44.4

726

4290

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

44.3

541

2822

DHB20

NOMESCO Finland

Polypectomy of internal nose

156.4

43.9

J33.8

ICD-10 Finland

Other polyp of sinus

435.7

43.3

XG466

NOMESCO Finland

Sleep oxymetry

9.5

42.0

DJD20

NOMESCO Finland

Plastic repair of septum of nose

149.5

41.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

41.2

388

1777

R05

ICPC

Cough

2.3

40.9

459

2290

J01DB01

ATC

cefalexin; oral

1.9

40.5

1641

13231

SPAT1325

SPAT

Vaccination

1.9

40.1

759

4700

A02BC01

ATC

omeprazole; systemic

2.1

39.4

549

3011

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

11.9

39.4

R05FB02

ATC

cough suppressants and expectorants

1.9

38.5

760

4763

R03BB02

ATC

oxitropium bromide; inhalant

43.5

38.2

J37.0

ICD-10 Finland

Chronic laryngitis

20.1

38.0

C03DA01

ATC

spironolactone; oral

3.6

37.9

183

542

A01AB09

ATC

miconazole; local oral

3.1

37.7

224

775

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

37.6

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

373.2

37.1

R03CC02

ATC

salbutamol; systemic

3.5

36.8

184

561

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

34.2

36.3

R50.9

ICD-10 Finland

Fever, unspecified

2.7

36.2

265

1049

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

362.8

36.1

J36

ICD-10 Finland

Peritonsillar abscess

128.7

35.8

R51.80

ICD-10 Finland

Headache

2.5

35.4

309

1352

N03AX12

ATC

gabapentin; oral

2.5

35.3

308

1345

J01FF01

ATC

clindamycin; systemic

2.1

35.3

502

2758

SPAT1057

SPAT

Peak expiratory flow measurement

9.5

35.1

A02BA02

ATC

ranitidine; systemic

2.2

34.9

390

1928

XG460

NOMESCO Finland

Short time oxymetry

13.7

34.5

EMB30

NOMESCO Finland

Adenotomy

11.1

34.5

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

34.5

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

34.5

E0000UV

ATC

1.8

33.9

807

5335

R05FA02

ATC

opium derivatives and expectorants; systemic

1.8

33.8

818

5438

RF210

NOMESCO Finland

5.8

33.5

176

R06.5

ICD-10 Finland

Mouth breathing

3.4

33.5

169

518

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

8.6

33.5

J02AC01

ATC

fluconazole; systemic

1.8

33.2

768

5023

RF120

NOMESCO Finland

13.3

32.4

HMAK

NOMESCO Finland

2.4

32.3

294

1308

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

32.9

32.2

SPAT1254

SPAT

Administration of medicine

2.3

32.0

318

1483

UDM02

NOMESCO Finland

Sinoscopy

22.3

31.8

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

115.0

31.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

31.6

591

3582

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

53.7

31.3

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

+∞

31.3

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

31.3

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

31.3

Z51.6

ICD-10 Finland

Desensitization to allergens

39.7

31.2

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

31.2

314

1470

L20.0

ICD-10 Finland

Besnier prurigo

3.1

31.1

179

605

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

30.6

232

932

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

30.3

676

4338

J01DA06

ATC

[U] cefuroxime; systemic

2.3

30.1

294

1356

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

11.7

30.1

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

83.7

29.8

N03AX16

ATC

pregabalin; oral

2.0

29.6

408

2197

SPAT1359

SPAT

Use of symptom diary

5.3

29.0

174

SPAT1263

SPAT

Sampling

1.7

29.0

840

5829

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

11.5

28.9

R81

ICPC

Pneumonia

8.6

28.8

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

151.9

28.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

28.3

642

4124

J96.0

ICD-10 Finland

Acute respiratory failure

+∞

28.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

27.9

125

348

J32.4

ICD-10 Finland

Chronic pansinusitis

78.6

27.8

E66.01

ICD-10 Finland

Obesity due to excess calories

3.1

27.6

162

553

S18

ICPC

Laceration/cut

1.7

27.5

779

5344

M79.6

ICD-10 Finland

Pain in limb

1.8

27.4

657

4288

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.7

27.1

191

736

SPAT1257

SPAT

Teaching of medicine inhalation technique

5.5

26.7

149

A07AA02

ATC

nystatin; oral

3.5

26.6

129

384

DHB50

NOMESCO Finland

Turbinoplasty

52.3

26.2

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.7

26.1

190

746

AN1

Coronary angiography

2.6

25.7

203

835

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

25.6

202

830

N05CF01

ATC

zopiclone; oral

1.8

25.4

579

3701

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

25.3

460

2727

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

25.3

314

1608

ZX120

NOMESCO Finland

Intravenous

2.7

25.3

178

685

N05BA04

ATC

oxazepam; oral

1.9

25.2

461

2738

N06AX21

ATC

duloxetine; oral

2.6

25.1

200

826

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

25.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

7.2

24.9

R03AC18

ATC

indacaterol; inhalant

131.4

24.6

T78.4

ICD-10 Finland

Allergy, unspecified

3.8

24.5

108

297

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.6

24.3

182

727

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

15.1

24.2

J01MA02

ATC

ciprofloxacin; systemic

1.7

24.2

704

4824

N06AX11

ATC

mirtazapine; oral

1.7

24.1

561

3601

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

24.0

501

3106

J01FA01

ATC

erythromycin; systemic

2.1

23.7

291

1482

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

23.1

324

1740

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

17.4

23.1

R01AC07

ATC

nedocromil; nasal

24.9

23.1

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

22.9

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

22.9

SPAT1131

SPAT

Colonoscopy

4.1

22.9

233

R60.0

ICD-10 Finland

Localized oedema

2.4

22.9

209

928

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

10.7

22.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

22.8

344

1901

C01AA05

ATC

digoxin; systemic

3.1

22.8

132

448

WQ000

NOMESCO Finland

Hyposensibilisation

84.3

22.7

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.2

22.6

140

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

20.9

22.6

SPAT1310

SPAT

Counselling related to known health issue

1.7

22.5

632

4267

S15

ICPC

Foreign body in skin

2.9

22.5

145

528

N06AA09

ATC

amitriptyline; systemic

2.5

22.5

186

783

J20

ICD-10 Finland

Acute bronchitis

2.6

22.4

168

670

M25.5

ICD-10 Finland

Pain in joint

1.8

22.4

500

3158

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

22.1

1000

7633

R03BB07

ATC

umeclidinium bromide; inhalant

35.4

22.1

R53

ICD-10 Finland

Malaise and fatigue

1.9

22.1

356

2014

D07AC13

ATC

mometasone; topical

1.7

21.9

534

3460

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

+∞

21.9

A01AB04

ATC

amphotericin B; local oral

3.4

21.9

109

332

M03BX02

ATC

tizanidine; oral

1.5

21.7

1109

8703

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

116.1

21.6

A46

ICD-10 Finland

Erysipelas

2.2

21.6

227

1076

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

21.5

310

1683

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.5

21.3

103

306

S01GX02

ATC

levocabastine; ophthalmic

2.9

21.2

136

491

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

21.1

338

1903

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.0

21.1

278

1457

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.2

21.0

239

1175

-1

NOMESCO Finland

1.6

20.9

675

4719

M01AE02

ATC

naproxen; oral, rectal

1.5

20.9

1079

8454

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

20.9

R42

ICD-10 Finland

Dizziness and giddiness

1.8

20.8

382

2259

P01AB01

ATC

metronidazole; oral, rectal

1.6

20.8

706

4998

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.8

20.8

136

501

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

211.8

20.6

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.9

20.6

222

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

20.5

149

585

N06AX16

ATC

venlafaxine; oral

2.1

20.3

250

1272

ZXA10

NOMESCO Finland

Bilateral

1.9

20.3

321

1800

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

20.3

256

1316

E000001

ATC

1.8

20.2

395

2382

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

20.2

640

4445

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

4.7

20.1

151

C08DA01

ATC

verapamil; systemic

3.6

20.0

258

B01AA03

ATC

warfarin; systemic

1.9

19.9

309

1719

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.5

19.8

162

E000002

ATC

2.1

19.8

240

1214

R29

ICPC

Respiratory symptom/complaint other

3.0

19.7

118

409

SPAT1216

SPAT

Assessment of functional ability

2.0

19.5

286

1559

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

8.5

19.4

J35.1

ICD-10 Finland

Hypertrophy of tonsils

46.4

19.2

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.7

19.2

140

549

R1250

NOMESCO Finland

Evaluation of functional capability

4.8

19.2

136

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

19.0

136

528

R49.08

ICD-10 Finland

Other specified dysphonia

6.9

19.0

H02AB09

ATC

hydrocortisone; systemic

5.4

18.9

108

R05CA10

ATC

expectorants - combinations

4.6

18.9

147

J01DA08

ATC

[U] cefaclor; oral

2.1

18.8

239

1232

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

18.8

R74

ICPC

Upper respiratory infection acute

1.6

18.6

514

3425

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

18.6

321

1853

Z00.8

ICD-10 Finland

Other general examinations

2.5

18.5

153

644

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.8

18.5

218

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

18.3

459

2978

H66.9

ICD-10 Finland

Otitis media, unspecified

2.8

18.2

124

467

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.0

18.2

186

M04AA01

ATC

allopurinol; systemic

2.2

18.2

197

947

GD1AD

NOMESCO Finland

Thorax CT examination

5.1

18.1

114

E66.8

ICD-10 Finland

Other obesity

3.2

18.0

309

J43.9

ICD-10 Finland

Emphysema, unspecified

33.2

18.0

M05BA04

ATC

alendronic acid; oral

2.5

17.9

147

617

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

4.3

17.8

161

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

17.7

132

Kela drug reimbursment

Sarcoidosis

+∞

17.7

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

17.7

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

17.7

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

17.7

197

959

L03

ICPC

Low back symptom/complaint

1.7

17.6

420

2680

I42.0

ICD-10 Finland

Dilated cardiomyopathy

9.4

17.6

R52.2

ICD-10 Finland

Other chronic pain

4.0

17.6

182

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.9

17.6

192

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

95.8

17.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

17.5

513

3467

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

29.0

17.4

I20.00

ICD-10 Finland

Unstable angina

4.5

17.3

142

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

17.2

880

6777

N05CD07

ATC

temazepam; oral

2.0

16.9

219

1135

R07.3

ICD-10 Finland

Other chest pain

2.3

16.9

162

736

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.3

16.8

274

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

16.8

357

2201

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

16.8

174

821

D07AC01

ATC

betamethasone; topical

1.6

16.7

591

4181

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

16.7

166

767

SPAT1301

SPAT

No procedures

1.6

16.7

593

4198

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

+∞

16.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

+∞

16.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

16.7

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

+∞

16.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

16.7

279

1590

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.0

16.7

167

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.0

16.7

231

1231

N02AA05

ATC

oxycodone; systemic

2.0

16.6

224

1179

R05CB01

ATC

acetylcysteine; inhalant, oral

7.3

16.5

N06AB04

ATC

citalopram; systemic

1.7

16.5

359

2229

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

8.3

16.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

16.5

505

3448

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

18.0

16.5

D07AA02

ATC

hydrocortisone; topical

1.9

16.3

274

1566

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

16.2

216

1132

Angiography of the heart and coronary arteries

2.7

16.2

112

427

N05BA01

ATC

diazepam; systemic, rectal

1.9

16.2

235

1273

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

6.6

16.1

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

24.6

16.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

16.0

256

1438

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

16.0

749

5636

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

15.9

217

1146

M01AH05

ATC

etoricoxib; oral

1.5

15.9

1015

8145

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.8

15.8

EMB20

NOMESCO Finland

Adenotonsillectomy

60.4

15.8

RP210

NOMESCO Finland

33.6

15.7

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

8.8

15.7

M48.0

ICD-10 Finland

Spinal stenosis

2.0

15.7

201

1038

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

+∞

15.6

N06AB03

ATC

fluoxetine; oral

2.0

15.6

223

1200

R06AX11

ATC

astemizole; oral

3.5

15.6

213

XG430

NOMESCO Finland

Spiroegometry

85.7

15.6

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

15.6

637

4646

SPAT1360

SPAT

Extensive global examination

2.3

15.5

150

683

RF430

NOMESCO Finland

22.2

15.5

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

161.0

15.5

N05BB01

ATC

hydroxyzine; systemic

2.4

15.5

134

580

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

15.4

697

5197

J01DC02

ATC

cefuroxime; systemic

2.8

15.3

356

SPAT1240

SPAT

Therapeutic discussion

2.0

15.1

205

1082

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

15.1

367

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

15.1

142

640

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

15.0

499

3464

E66.9

ICD-10 Finland

Obesity, unspecified

3.6

14.9

190

R28

ICPC

Limited function/disability (R)

11.4

14.8

XA402

NOMESCO Finland

ENMG

3.8

14.7

162

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.8

14.7

342

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

14.6

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

+∞

14.6

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.9

14.5

154

M01AH02

ATC

rofecoxib; oral

1.9

14.4

219

1204

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

15.5

14.4

I45.9

ICD-10 Finland

Conduction disorder, unspecified

12.6

14.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

14.4

134

599

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

27.3

14.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

14.2

415

2785

A06AD11

ATC

lactulose; oral

1.9

14.2

234

1323

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

14.2

162

R49.01

ICD-10 Finland

Functional dysphonia

4.0

14.1

143

Z51.0

ICD-10 Finland

Radiotherapy session

5.2

14.1

SPAT1153

SPAT

Removal of sutures

1.5

14.0

544

3903

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

14.0

346

2220

M10.9

ICD-10 Finland

Gout, unspecified

2.8

14.0

336

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

6.1

13.9

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

6.1

13.9

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

13.9

142

665

B01AC04

ATC

clopidogrel; oral

1.8

13.9

231

1312

R52.9

ICD-10 Finland

Pain, unspecified

2.2

13.8

148

708

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

13.7

1317

11272

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

13.7

276

1665

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

13.6

374

2469

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

13.6

236

1359

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.0

13.6

138

UDQ02

NOMESCO Finland

Direct laryngoscopy

14.8

13.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

13.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

13.5

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

13.5

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

13.5

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

13.5

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

13.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

13.5

256

1516

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

34.2

13.5

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.2

13.5

223

J42

ICD-10 Finland

Unspecified chronic bronchitis

10.1

13.5

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

140.8

13.5

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

16.3

13.4

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.1

13.4

240

SPAT1260

SPAT

Consultation of another employee

1.7

13.4

307

1926

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

13.4

152

743

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.4

13.4

111

467

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

13.4

133

616

R83

ICPC

Respiratory infection other

1.6

13.3

440

3038

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

13.3

195

1059

J30.0

ICD-10 Finland

Vasomotor rhinitis

5.6

13.3

UJF32

NOMESCO Finland

Coloscopy

1.6

13.2

394

2653

N06AA12

ATC

doxepin; systemic

2.6

13.2

367

WX722

NOMESCO Finland

PEEP

3.4

13.0

185

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

13.0

307

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

28.5

13.0

SPAT1097

SPAT

Recording of ECG

1.8

12.9

244

1443

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.6

12.9

160

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

12.9

703

5402

J33.9

ICD-10 Finland

Nasal polyp, unspecified

13.0

12.9

A03

ICPC

Fever

1.7

12.9

273

1673

M79.7

ICD-10 Finland

Fibromyalgia

3.6

12.8

166

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.2

12.8

117

D02AE01

ATC

carbamide; topical

2.3

12.7

121

548

N06AX03

ATC

mianserin; oral

2.8

12.7

291

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

12.6

104

439

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

12.6

394

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

12.6

112

491

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

70.2

12.6

C08CA01

ATC

amlodipine; oral

1.5

12.6

550

4037

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

32.2

12.6

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

8.3

12.5

N05AH04

ATC

quetiapine; oral

1.7

12.5

273

1686

C08CA13

ATC

lercanidipine; oral

1.8

12.5

209

1189

348

Kela drug reimbursment

Roflumilast

+∞

12.5

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

+∞

12.5

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

+∞

12.5

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

12.5

GDC00

NOMESCO Finland

Lobectomy of lung

+∞

12.5

RF421

NOMESCO Finland

10.1

12.5

XQ848

NOMESCO Finland

Dermatological photography

3.4

12.5

181

J94.8

ICD-10 Finland

Other specified pleural conditions

130.6

12.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

12.4

143

708

C09CA01

ATC

losartan; oral

1.6

12.4

371

2499

S22.3

ICD-10 Finland

Fracture of rib

2.4

12.4

103

439

C08DB01

ATC

diltiazem; oral

2.5

12.3

388

C01DA14

ATC

isosorbide mononitrate; oral

1.8

12.2

224

1310

J04.0

ICD-10 Finland

Acute laryngitis

3.7

12.1

143

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

16.0

12.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

12.1

258

1585

PLAK1

NOMESCO Finland

5.3

12.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

12.1

119

548

A03FA02

ATC

cisapride; oral, rectal

2.1

12.0

140

694

N18.8

ICD-10 Finland

Other chronic renal failure

4.2

12.0

110

RF220

NOMESCO Finland

5.1

12.0

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

12.0

220

1291

PLAK0

NOMESCO Finland

5.8

11.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

11.9

296

Z72.0

ICD-10 Finland

Tobacco use

4.6

11.9

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

11.9

267

D07BC01

ATC

betamethasone and antiseptics; topical

1.8

11.9

205

1178

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

11.8

732

5743

M01AC06

ATC

meloxicam; systemic, rectal

1.4

11.8

600

4536

R03DA05

ATC

aminophylline; systemic, rectal

10.6

11.7

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

10.6

11.7

WW200

NOMESCO Finland

Immunization

3.8

11.7

132

EBA00

NOMESCO Finland

Extraction of tooth

1.4

11.7

592

4468

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.3

11.7

106

469

K30

ICD-10 Finland

Functional dyspepsia

1.9

11.7

165

886

E000006

ATC

2.1

11.6

126

607

WX308

NOMESCO Finland

Sacral anesthesy

12.6

11.6

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

11.6

381

2620

Z50.5

ICD-10 Finland

Speech therapy

4.9

11.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

11.6

118

553

C10AA01

ATC

simvastatin; oral

1.4

11.5

699

5451

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

11.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

11.5

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

+∞

11.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

11.5

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

11.5

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

13.7

11.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

11.4

198

1139

J98.1

ICD-10 Finland

Pulmonary collapse

120.6

11.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.6

11.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

11.4

154

812

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

15.1

11.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

11.3

274

1745

GD1AA

SPAT

2.2

11.3

112

521

DPA30

NOMESCO Finland

Sphenotomy

35.2

11.3

J92.9

ICD-10 Finland

Pleural plaque without asbestos

35.2

11.3

49099

ICD-8 Finland

Bronchitis, unspecified

6.6

11.2

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

11.2

236

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

11.2

157

839

G44.2

ICD-10 Finland

Tension-type headache

1.8

11.2

205

1202

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.4

11.2

R03AC19

ATC

olodaterol; inhalant

25.1

11.1

50708

ICD-8 Finland

Hay fever, Alia definita

12.8

11.1

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

11.1

248

S01GX08

ATC

ketotifen; ophthalmic

2.8

11.1

262

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

11.0

954

7897

RD210

NOMESCO Finland

4.2

10.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

10.9

339

2298

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

10.8

339

TQW80

NOMESCO Finland

Local dermatologic skincare

3.3

10.8

158

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

10.8

296

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

4.6

10.8

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

10.8

469

3429

H01

ICPC

Ear pain/earache

1.8

10.8

185

1062

I20.09

ICD-10 Finland

Unstable angina

2.5

10.7

351

K05

ICPC

Irregular heartbeat other

2.9

10.7

232

J01EA01

ATC

trimethoprim; systemic

1.5

10.7

438

3160

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

10.7

358

2472

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.8

10.7

118

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

7.6

10.7

J32.1

ICD-10 Finland

Chronic frontal sinusitis

60.3

10.6

J38.2

ICD-10 Finland

Nodules of vocal cords

60.3

10.6

G04CA02

ATC

tamsulosin; oral

1.5

10.6

339

2311

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

10.4

391

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

10.4

R03DX07

ATC

roflumilast; oral

+∞

10.4

A11CC03

ATC

alfacalcidol; systemic

4.7

10.4

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

10.4

405

2889

N06AB10

ATC

escitalopram; oral

1.5

10.4

328

2232

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

4.8

10.4

R07

ICPC

Sneezing/nasal congestion

2.1

10.4

115

562

A02BA04

ATC

nizatidine; systemic

2.0

10.3

130

668

N03AE01

ATC

clonazepam; systemic

2.3

10.3

394

R03AC04

ATC

fenoterol; inhalant

32.7

10.3

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

10.3

252

1607

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

10.3

142

757

I45.8

ICD-10 Finland

Other specified conduction disorders

10.6

10.3

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

5.8

10.3

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

10.3

181

1050

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

10.3

400

J41.0

ICD-10 Finland

Simple chronic bronchitis

23.5

10.2

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

10.2

170

967

A12BA01

ATC

potassium chloride; oral

2.6

10.2

281

ZX114

NOMESCO Finland

Intramuscular

5.1

10.2

RF313

NOMESCO Finland

13.2

10.1

N07BA03

ATC

varenicline; oral

2.6

10.1

289

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.7

10.1

241

KHV

NOMESCO Finland

5.7

10.1

R01AX03

ATC

ipratropium bromide; nasal

3.9

10.1

104

A10BA02

ATC

metformin; oral

1.5

10.1

417

3010

J05AH02

ATC

oseltamivir; oral

8.5

10.0

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

10.0

253

R01AC02

ATC

levocabastine; nasal

3.1

10.0

168

M10.0

ICD-10 Finland

Idiopathic gout

3.2

10.0

157

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

14.6

10.0

S97

ICPC

Chronic ulcer skin

2.5

10.0

297

M02AA07

ATC

piroxicam; topical

1.4

9.9

591

4572

R2110

NOMESCO Finland

Giving the first information

2.0

9.9

120

606

A10BJ06

ATC

semaglutide; parenteral

3.2

9.9

158

SPAT1255

SPAT

Intravenous administration of medicine

2.3

9.9

415

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

12.2

9.8

ZX108

NOMESCO Finland

Inhalation

26.1

9.8

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

20.1

9.8

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

9.8

106

513

X58

ICD-10 Finland

Exposure to other specified factors

1.7

9.8

218

1354

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

9.7

427

RJ190

NOMESCO Finland

13.4

9.7

R06AX12

ATC

terfenadine; oral

2.3

9.6

366

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

9.6

298

S80.0

ICD-10 Finland

Contusion of knee

2.1

9.6

107

526

4226

FHL

Posterior radical surgery and possible etmoidectomy

8.4

9.5

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

5.0

9.5

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.0

9.5

115

580

D07AD01

ATC

clobetasol; topical

1.6

9.5

241

1550

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.6

9.5

275

J03.0

ICD-10 Finland

Streptococcal tonsillitis

3.7

9.5

110

R4110

SPAT

2.9

9.5

191

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.9

9.4

198

V01AA02

ATC

grass pollen; systemic

100.4

9.4

SPAT1060

SPAT

Administration of oxygen

100.4

9.4

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

100.4

9.4

4239

FHL

Other measure in this category

30.1

9.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

9.4

246

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

+∞

9.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

9.4

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

9.4

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

8.1

9.3

SPAT1098

SPAT

Exercise ECG

3.2

9.3

144

4222

FHL

Endonasal etmoidectomy

9.5

9.3

A28

ICPC

Limited function/disability NOS

1.7

9.3

213

1334

280

Kela drug reimbursment

Clopidogrel

5.0

9.2

R55

ICD-10 Finland

Syncope and collapse

1.8

9.2

163

948

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.5

9.1

J30.19

ICD-10 Finland

Pollen allergy UNS

3.1

9.1

157

AN2

Balloon angioplasty, including several vessels

3.0

9.1

177

L28

ICPC

Limited function/disability (L)

1.6

9.1

229

1471

M05BA07

ATC

risedronic acid; oral

2.8

9.1

214

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

9.1

309

2134

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.0

9.1

178

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

5.1

9.1

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

9.1

177

1059

J01.1

ICD-10 Finland

Acute frontal sinusitis

8.3

9.1

S01ED02

ATC

betaxolol; ophthalmic

5.4

9.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

9.0

185

1120

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.5

9.0

115

M79.1

ICD-10 Finland

Myalgia

1.7

9.0

198

1223

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.4

9.0

302

L29.9

ICD-10 Finland

Pruritus, unspecified

3.6

9.0

110

ZXC60

NOMESCO Finland

Application of heat

7.1

9.0

C01BD01

ATC

amiodarone; systemic

3.7

9.0

105

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

9.0

300

2065

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

8.9

218

1388

A02BX02

ATC

sucralfate; oral

2.4

8.9

297

J01.4

ICD-10 Finland

Acute pansinusitis

24.1

8.9

R03DB04

ATC

theophylline and adrenergics; systemic

24.1

8.9

Z08

ICPC

Social welfare problem

5.5

8.9

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

8.9

445

N02AC04

ATC

dextropropoxyphene; oral

2.5

8.9

261

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

8.9

280

1904

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

8.9

176

L50.0

ICD-10 Finland

Allergic urticaria

2.9

8.9

176

R39

ICPC

Respiratory, Physical function test

8.0

8.8

ZX140

NOMESCO Finland

Intra articular

6.8

8.8

4224

FHL

Endonasal anthrostomy

6.8

8.8

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

8.8

126

680

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.9

8.8

184

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

8.8

143

808

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

8.8

263

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

8.8

148

845

R21

ICPC

Throat symptom/complaint

1.5

8.8

337

2392

E000003

ATC

2.3

8.8

364

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

8.8

159

932

H57.1

ICD-10 Finland

Ocular pain

2.8

8.7

201

N39.3

ICD-10 Finland

Stress incontinence

2.0

8.7

113

589

R03BB05

ATC

aclidinium bromide; inhalant

50.2

8.7

J38.4

ICD-10 Finland

Oedema of larynx

50.2

8.7

R01BA01

ATC

phenylpropanolamine; oral

2.2

8.7

401

R09

ICPC

Sinus symptom/complaint

1.9

8.6

117

621

H03AA01

ATC

levothyroxine sodium; systemic

1.5

8.6

370

2684

I47.2

ICD-10 Finland

Ventricular tachycardia

3.9

8.6

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

8.6

106

541

ZX100

NOMESCO Finland

Oral

4.3

8.6

XA420

NOMESCO Finland

Extensive sleep examination

5.3

8.6

R13

ICD-10 Finland

Dysphagia

2.2

8.6

395

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

16.3

8.5

L01

ICPC

Neck symptom/complaint

1.6

8.5

214

1376

N03AX09

ATC

lamotrigine; oral

2.4

8.5

303

C09CA06

ATC

candesartan; oral

1.5

8.5

326

2312

RJ410

NOMESCO Finland

10.1

8.5

S06.0

ICD-10 Finland

Concussion

1.7

8.5

165

983

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

8.5

146

840

C07AB05

ATC

betaxolol; oral

2.8

8.5

199

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

8.5

1252

11046

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

8.5

345

J38.3

ICD-10 Finland

Other diseases of vocal cords

27.6

8.5

J15.8

ICD-10 Finland

Other bacterial pneumonia

27.6

8.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

8.5

140

793

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.6

8.5

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.0

8.4

155

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.4

8.4

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

90.3

8.4

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

90.3

8.4

B02.9

ICD-10 Finland

Zoster without complication

2.2

8.4

393

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

8.4

299

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

8.3

219

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

+∞

8.3

J93.9

ICD-10 Finland

Pneumothorax, unspecified

+∞

8.3

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

8.3

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

51899

ICD-8 Finland

Bronchiectasis

+∞

8.3

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

8.3

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

8.3

110

576

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

4.6

8.3

R01AD

ATC

Corticosteroids

5.8

8.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

8.3

153

902

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

8.2

168

SPAT1229

SPAT

Assessment of need for aid

1.9

8.2

112

596

R03CC03

ATC

terbutaline; systemic

3.0

8.2

161

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

8.2

182

1129

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

8.2

379

K59.0

ICD-10 Finland

Constipation

2.1

8.2

427

R11

ICD-10 Finland

Nausea and vomiting

1.9

8.2

117

633

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.5

8.2

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

8.1

148

867

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.3

8.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

8.1

235

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

8.1

214

1393

N04BC05

ATC

pramipexole; oral

1.9

8.1

112

597

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

33.4

8.1

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

8.1

375

N05BA12

ATC

alprazolam; oral

1.7

8.1

149

877

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.4

8.1

273

205

Kela drug reimbursment

Chronic hypertension

1.4

8.0

448

3408

SPAT1211

SPAT

Application of soft bandage

1.7

8.0

149

879

RF212

NOMESCO Finland

8.9

8.0

D07AB08

ATC

desonide; topical

1.7

8.0

171

1052

RJ421

NOMESCO Finland

10.1

8.0

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.0

8.0

104

544

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.1

8.0

390

WZC30

SPAT

3.2

8.0

122

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

8.0

199

1276

E000007

ATC

2.0

8.0

507

RJ411

NOMESCO Finland

7.2

8.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

7.9

279

1940

H92.0

ICD-10 Finland

Otalgia

2.1

7.9

399

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.1

7.9

129

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

7.9

103

541

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

7.9

135

777

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

7.8

345

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

7.7

256

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

45.1

7.7

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

7.7

257

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

7.7

308

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

7.7

410

E66.0

ICD-10 Finland

Obesity due to excess calories

5.3

7.7

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

7.7

161

987

J05AB01

ATC

aciclovir; systemic

1.4

7.7

330

2395

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.5

7.6

224

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.6

7.6

206

1348

B02AA02

ATC

tranexamic acid; systemic

1.6

7.6

224

1497

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.4

7.6

271

U01

ICPC

Dysuria/painful urination

1.8

7.6

122

688

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

25.1

7.6

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

7.6

163

1006

R03BA07

ATC

mometasone; inhalant

6.2

7.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.5

653

5325

M54.2

ICD-10 Finland

Cervicalgia

1.9

7.5

102

542

J01AA04

ATC

lymecycline; systemic

1.6

7.5

211

1395

I95.9

ICD-10 Finland

Hypotension, unspecified

5.4

7.5

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

7.5

448

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

7.5

363

2695

D11AH01

ATC

tacrolimus; topical

4.8

7.4

K77

ICPC

Heart failure

4.8

7.4

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

80.3

7.4

4719X

ICD-9 Finland

Nasal polyps, Unspecified nasal polyp

80.3

7.4

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

80.3

7.4

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

7.4

334

ZXA00

NOMESCO Finland

Right side

1.4

7.4

405

3068

M02AA10

ATC

ketoprofen; topical

1.5

7.4

250

1724

R05CB02

ATC

bromhexine; systemic

3.5

7.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.4

7.4

262

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

7.3

103

556

M01AG01

ATC

mefenamic acid; oral

2.8

7.3

165

R5599

NOMESCO Finland

Other rehabilitation service

2.7

7.3

175

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

7.3

447

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

7.3

116

654

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

+∞

7.3

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

7.3

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

+∞

7.3

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

7.3

NOMESCO Finland

Other rehabilitation services

+∞

7.3

UJC12

NOMESCO Finland

Flexible oesophagoscopy

6.8

7.3

WZA10

NOMESCO Finland

Long statement of health and health related matters

4.0

7.3

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

7.2

423

3242

KMAK

NOMESCO Finland

1.3

7.2

890

7602

T90

ICPC

Diabetes non-insulin dependent

1.4

7.2

311

2257

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

7.2

148

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

5.8

7.2

R06AX18

ATC

acrivastine; oral

2.7

7.2

171

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

7.3

7.2

R04

ICPC

Breathing problem other

2.6

7.2

196

L16

ICPC

Ankle symptom/complaint

1.7

7.2

151

927

M01AX17

ATC

nimesulide; oral

1.4

7.2

365

2733

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

30.1

7.1

J96.9

ICD-10 Finland

Respiratory failure, unspecified

30.1

7.1

S20.2

ICD-10 Finland

Contusion of thorax

2.2

7.1

335

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

20.1

7.1

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

7.1

218

1470

P01

ICPC

Feeling anxious/nervous/tense

1.6

7.1

176

1128

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

7.1

294

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.1

212

1420

C02DE04

ATC

2.7

7.1

174

A02BC04

ATC

rabeprazole; oral

1.8

7.1

119

681

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

3.7

7.1

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.6

7.0

191

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.0

7.0

129

RF122

NOMESCO Finland

10.0

7.0

Y0499

ICD-8 Finland

Investigation of respiratory system

4.3

7.0

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

7.0

449

3489

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

7.0

485

F03

ICPC

Eye discharge

1.9

7.0

104

574

Z01.2

ICD-10 Finland

Dental examination

1.3

7.0

708

5893

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

7.0

332

48509

ICD-8 Finland

Bronchopneumonia, unspecified

4.5

6.9

160

Kela drug reimbursment

exenatide

3.3

6.9

N06BA04

ATC

methylphenidate; oral

2.8

6.9

147

207

Kela drug reimbursment

Chronic arrhythmias

1.6

6.9

177

1144

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

6.9

121

701

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

6.9

326

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.6

6.9

S16

ICPC

Bruise/contusion

2.6

6.9

188

UDC00

NOMESCO Finland

Ear microscopy

1.8

6.8

108

606

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.4

6.8

315

Kela drug reimbursment

Clopidogrel

5.0

6.8

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.0

6.8

121

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

6.8

165

1054

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

6.8

240

1673

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.6

6.8

180

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

6.8

370

R49.09

ICD-10 Finland

Unspecified dysphonia

6.1

6.8

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

40.2

6.8

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.5

6.7

199

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

6.7

217

1483

Z29.0

ICD-10 Finland

Isolation

16.7

6.7

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

6.7

116

DFF15

NOMESCO Finland

Speech audiometry

2.1

6.7

351

ZXA05

NOMESCO Finland

Left side

1.4

6.7

386

2951

J38.7

ICD-10 Finland

Other diseases of larynx

22.6

6.7

R63.4

ICD-10 Finland

Abnormal weight loss

2.5

6.7

204

RF310

NOMESCO Finland

7.8

6.6

G43.3

ICD-10 Finland

Complicated migraine

3.4

6.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

6.6

382

2918

P29

ICPC

Psychological sympt/compl other

1.9

6.6

505

-42

ICPC

Electrical tracing

3.5

6.6

F60.5

ICD-10 Finland

Anankastic personality disorder

4.6

6.6

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

12.3

6.6

A01AB10

ATC

natamycin; local oral

2.4

6.6

207

M54.3

ICD-10 Finland

Sciatica

1.9

6.6

451

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.2

6.6

311

C03AA03

ATC

hydrochlorothiazide; oral

1.7

6.6

137

840

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

6.5

542

WX290

NOMESCO Finland

Other blockade of nerve

1.3

6.5

739

6225

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

6.5

100

559

R06.4

ICD-10 Finland

Hyperventilation

3.6

6.5

XQ802

NOMESCO Finland

Epicutan test

2.2

6.5

269

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

6.5

913

7905

A12AA04

ATC

calcium carbonate; oral

4.5

6.5

A10BX04

ATC

[U] exenatide; parenteral

4.5

6.5

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

5.3

6.5

C09AA05

ATC

ramipril; oral

1.4

6.4

323

2409

SPAT1283

SPAT

Restricted health certificate

1.4

6.4

294

2152

V01AA05

ATC

tree pollen; parenteral

5.7

6.4

L04AX01

ATC

azathioprine; systemic

2.2

6.4

273

T82

ICPC

Obesity

2.4

6.4

222

XG488

NOMESCO Finland

Other provokation of respiratroy tract

70.0

6.4

DMB10

NOMESCO Finland

Radical maxillary antrotomy

70.0

6.4

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

70.0

6.4

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

70.0

6.4

I27.0

ICD-10 Finland

Primary pulmonary hypertension

70.0

6.4

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

6.4

358

2718

R05DB05

ATC

pentoxyverine; oral, rectal

2.3

6.4

231

SPAT1262

SPAT

Handing over of treatment supplies

1.5

6.4

249

1771

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

6.4

437

S87

ICPC

Dermatitis/atopic eczema

2.5

6.4

186

SPAT1043

SPAT

Audiometry

1.6

6.4

168

1093

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.4

225

1568

B03XA02

ATC

darbepoetin alfa; parenteral

4.4

6.3

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.4

6.3

XKX00

NOMESCO Finland

Pelvic floor electromyography

8.2

6.3

S81.0

ICD-10 Finland

Open wound of knee

3.4

6.3

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

6.3

128

779

R04.0

ICD-10 Finland

Epistaxis

1.8

6.3

519

D10

ICPC

Vomiting

1.8

6.3

519

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

6.3

188

RJ511

NOMESCO Finland

11.0

6.3

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

6.3

197

1335

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.9

6.3

125

RF110

NOMESCO Finland

9.3

6.3

XG405

SPAT

9.3

6.3

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.3

6.3

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

6.3

418

RK322

NOMESCO Finland

18.1

6.3

C08CA02

ATC

felodipine; oral

1.7

6.3

131

805

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

3.3

6.3

RD140

NOMESCO Finland

+∞

6.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.2

J86.9

ICD-10 Finland

Pyothorax without fistula

+∞

6.2

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

+∞

6.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.2

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

6.2

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

6.2

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.2

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

6.2

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

6.2

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.2

J94.9

ICD-10 Finland

Pleural condition, unspecified

+∞

6.2

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

6.2

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

6.2

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.7

6.2

140

S76

ICPC

Skin infection other

2.0

6.2

355

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

26.7

6.2

R03BB06

ATC

glycopyrronium bromide; inhalant

26.7

6.2

SPAT1267

SPAT

Desensitisation

26.7

6.2

Z51.88

ICD-10 Finland

Other specified medical care

3.0

6.2

106

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

6.2

521

4213

SPAT1324

SPAT

Screening procedure

1.4

6.2

283

2073

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

6.2

425

N05BE01

ATC

buspirone; oral

2.7

6.2

150

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

6.2

484

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

6.2

398

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.2

982

8604

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

6.2

133

822

S29

ICPC

Skin symptom/complaint other

1.4

6.2

249

1784

B37.08

ICD-10 Finland

Other candidal stomatitis

6.3

6.2

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

6.3

6.2

C08CA05

ATC

nifedipine; systemic

1.8

6.1

102

585

UDQ22

NOMESCO Finland

Microlaryngoscopy

7.7

6.1

U02

ICPC

Urinary frequency/urgency

1.5

6.1

202

1386

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.1

6.1

325

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

6.1

248

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

3.1

6.1

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

6.1

165

1085

R10.0

ICD-10 Finland

Acute abdomen

2.4

6.0

198

N03AG01

ATC

valproic acid; systemic, rectal

1.9

6.0

424

Y1202

ICD-8 Finland

Skin tests, Allergy tests

10.0

6.0

XF640

NOMESCO Finland

2.6

6.0

162

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.0

965

8456

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

337

601

6.33

184.59

1.5

1.1

325.76

188.01

u/ml

0.98

324

549

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

37.80

124.36

1.3

1.0

1.36

—

u/ml

—

(3021440) Promyelocytes/100 leukocytes in Blood

371

1114

3.74

105.18

4.3

3.9

0.05

0.11

0.93

249

(3017181) Myelocytes/100 leukocytes in Blood

378

1154

3.69

104.53

4.3

3.8

0.63

0.77

0.39

273

(3023419) Bacteria identified in Sputum by Culture

26.45

104.11

3.0

1.1

—

(3025159) Blasts/100 leukocytes in Blood

359

1064

3.78

103.68

4.3

3.9

0.02

0.50

0.71

217

(3002179) Metamyelocytes/100 leukocytes in Blood

337

1060

3.52

88.37

3.9

3.6

0.41

0.52

0.31

197

(3013115) Eosinophils [#/volume] in Blood

1278

7911

2.28

85.79

6.1

5.1

0.21

0.18

e9/l

7.83

1198

6840

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

40.82

85.58

4.3

2.5

—

(3022096) Basophils/100 leukocytes in Blood

1150

6884

2.25

82.90

6.0

5.1

0.67

0.69

0.80

1110

6341

(3006504) Eosinophils/100 leukocytes in Blood

1169

7155

2.20

78.47

6.0

5.0

3.07

2.83

2.28

1126

6577

(3042631) Mycobacterium sp identified in Specimen

14.30

77.70

3.7

2.0

—

(3019069) Monocytes/100 leukocytes in Blood

1171

7206

2.19

77.15

6.2

5.2

8.48

8.52

0.16

1131

6678

(3002030) Lymphocytes/100 leukocytes in Blood

1197

7497

2.16

74.61

6.1

5.1

27.55

29.86

11.96

1156

6903

(3001604) Monocytes [#/volume] in Blood

1211

7630

2.15

74.19

5.8

4.9

0.61

0.55

e9/l

14.91

1126

6468

(3018010) Neutrophils/100 leukocytes in Blood

1184

7400

2.15

74.02

5.8

4.9

57.62

55.77

6.51

1144

6846

(3006315) Basophils [#/volume] in Blood

1214

7667

2.15

73.80

5.9

4.9

0.04

e9/l

3.49

1129

6506

(3019198) Lymphocytes [#/volume] in Blood

1237

7957

2.11

70.64

5.8

4.9

1.94

1.98

e9/l

0.35

1169

6885

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

16.94

69.51

1.1

—

(4010399)

224

636

3.77

67.93

1.6

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

102

148

7.14

67.13

3.2

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

9.89

65.60

2.0

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

113

190

6.18

64.59

1.2

1.0

1.82

1.04

u/ml

0.54

(3000492) Spirometry study

303

1100

3.00

61.72

1.5

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

401

1696

2.63

61.07

2.1

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

665

3541

2.20

60.10

4.3

3.7

—

(3023368) Bacteria identified in Blood by Culture

603

3179

2.19

55.25

4.5

3.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

111

232

4.96

50.06

1.2

1.1

2.03

1.13

u/ml

0.44

(3036481) Cortisol [Moles/volume] in Serum or Plasma

297

1208

2.66

48.36

2.3

2.0

315.64

379.45

nmol/l

7.36

278

1111

(3021589) Normoblasts [#/volume] in Blood

1114

7584

1.85

47.50

10.9

7.4

0.00

e9/l

1.15

1006

6184

(3013650) Neutrophils [#/volume] in Blood by Automated count

1299

9282

1.84

47.28

8.8

7.4

4.34

3.88

e9/l

12.26

1213

7984

(3003888) Timothy IgE Ab [Units/volume] in Serum

100

209

4.94

45.09

1.1

1.0

4.95

5.06

u/ml

0.02

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

5.33

44.82

1.2

1.0

6.95

2.83

u/ml

0.91

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

874

5595

1.87

44.62

3.7

2.7

30.14

49.22

ng/l

1.51

588

3615

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

630

3636

1.98

43.88

3.2

2.0

1200.40

755.66

ng/l

2.58

540

3047

(3015235) Bicarbonate [Moles/volume] in Capillary blood

105

235

4.62

43.60

3.2

2.3

25.00

24.04

mmol/l

1.21

206

(3008401) Mugwort IgE Ab [Units/volume] in Serum

203

4.83

41.72

1.1

1.0

0.33

2.59

u/ml

1.48

(3021901) Oxygen saturation in Capillary blood

151

5.51

41.53

2.3

2.2

—

(3017569) Oxygen content in Arterial blood

10.14

35.40

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

258

1140

2.41

34.86

2.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

256

1131

2.41

34.60

2.1

1.4

—

(3016502) Oxygen saturation in Arterial blood

252

1112

2.41

34.13

5.0

6.0

94.90

96.62

4.15

238

1071

(3027801) Oxygen [Partial pressure] in Arterial blood

270

1237

2.33

33.57

5.2

5.6

10.94

14.18

kpa

21.02

256

1188

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

270

1239

2.32

33.44

5.2

5.6

5.21

5.01

kpa

2.55

255

1190

(3022217) INR in Platelet poor plasma by Coagulation assay

346

1770

2.11

32.73

17.4

20.6

1.22

1.30

inr

0.60

301

(3019060) Gas panel - Arterial blood

173

650

2.79

32.57

3.7

3.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

135

442

3.17

32.48

2.0

1.2

39.12

38.13

u/l

0.21

125

387

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

151

4.81

31.37

1.1

1.0

0.23

0.22

u/ml

0.03

(3023430) Cat dander IgE Ab [Units/volume] in Serum

164

4.55

30.19

1.1

1.0

5.55

4.29

u/ml

0.25

(3028626) Oxygen [Partial pressure] in Capillary blood

100

285

3.61

29.94

2.8

3.3

8.45

9.15

kpa

3.39

268

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

176

712

2.58

28.60

3.9

2.9

5.26

5.00

kpa

2.98

162

659

(3009343) pH of Capillary blood

174

702

2.59

28.44

3.9

2.9

7.43

7.42

0.28

(3003396) Base excess in Arterial blood by calculation

257

1241

2.19

28.00

5.3

5.6

1.77

0.44

mmol/l

6.95

203

945

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

7.86

27.66

2.7

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

707

4762

1.68

27.46

2.8

2.2

52.88

59.82

u/l

4.60

663

4360

(3041096) Erythrocytes [Presence] in Urine by Automated

699

4697

1.68

27.38

3.5

2.9

—

(42870588) Differential panel, method unspecified - Blood

719

4893

1.66

26.71

6.2

5.1

—

(4015189)

19.24

26.56

2.6

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1229

9570

1.57

25.67

4.7

3.4

6.43

6.58

mmol/l

2.29

1153

8737

(3005719) IgG [Mass/volume] in Serum or Plasma

206

942

2.29

25.55

2.6

2.1

9.75

10.74

g/l

2.96

200

844

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

164

678

2.52

25.46

1.8

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1555

12789

1.58

25.43

4.8

3.3

12.65

10.58

mm/h

6.82

1494

11727

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

163

674

2.52

25.29

3.8

2.9

2.66

0.94

mmol/l

7.51

106

458

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

500

3141

1.74

24.75

1.9

1.5

0.97

1.18

mg/l

1.25

380

2337

(3008152) Bicarbonate [Moles/volume] in Arterial blood

164

696

2.45

24.06

4.9

5.5

25.50

24.10

mmol/l

4.17

155

637

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1057

8069

1.54

23.38

5.8

4.9

11.09

12.00

umol/l

1.24

1009

7586

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

126

477

2.73

23.35

2.1

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.52

22.43

1.7

1.3

2.54

2.89

g/l

0.77

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.52

22.43

1.7

1.3

0.33

0.39

g/l

0.66

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.52

22.43

1.7

1.3

6.12

7.32

g/l

1.17

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1023

7803

1.53

22.42

6.9

4.9

1.22

mmol/l

0.09

903

6550

(4062490)

5.45

22.13

1.9

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

243

1257

2.03

21.96

3.5

3.1

1.23

mmol/l

0.16

227

1051

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

307

3.07

21.46

2.3

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

9.05

21.19

4.2

2.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

180

844

2.22

20.97

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

285

1591

1.89

20.59

1.9

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

233

3.33

20.40

1.8

1.2

7.88

9.96

mg/l

1.58

209

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

157

3.89

20.37

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

125

4.23

19.79

1.3

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

125

4.23

19.79

1.3

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

124

506

2.53

19.78

3.4

3.5

0.76

0.90

3.45

115

473

(3037522) Nuclear Ab [Titer] in Serum

325

1915

1.80

19.72

1.5

1.3

392.80

602.22

titre

1.57

378

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

415

2636

1.69

19.28

1.3

1.2

24.39

30.59

iu/ml

0.62

120

823

(3042936) Bacteria identified in Isolate by Culture

306

1798

1.80

18.70

2.2

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

187

937

2.08

18.37

3.9

1.9

111.95

114.46

ng/l

0.06

166

838

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

5.53

18.37

1.4

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

110

442

2.56

18.13

2.1

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

121

510

2.44

18.03

3.3

3.5

1.94

1.57

1.21

114

478

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

11.25

17.99

1.5

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

6.06

17.31

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

203

1073

1.97

17.19

5.6

6.1

123.22

122.03

g/l

0.31

198

1025

(3028026) IgM [Mass/volume] in Serum or Plasma

156

751

2.15

17.01

1.7

1.30

1.37

g/l

0.17

150

673

(3029937) Albumin [Presence] in Urine by Test strip

643

4663

1.51

16.78

4.1

3.4

0.00

estimate

0.69

328

1503

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

909

7067

1.45

16.68

2.5

2.1

77.54

77.40

nmol/l

0.05

857

6377

(3022948) Iron [Moles/volume] in Serum or Plasma

343

2149

1.69

16.62

2.7

2.1

14.21

13.98

umol/l

0.13

323

1965

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

872

6737

1.45

16.50

3.9

3.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

338

2.69

16.45

1.6

1.5

105.71

423.16

titre

—

(3026493) Urate [Moles/volume] in Serum or Plasma

554

3914

1.54

16.27

2.7

2.2

3313.10

6172.31

umol/l

1.04

513

3439

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

151

3.56

15.98

1.4

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.24

15.76

1.6

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.78

15.65

1.7

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

4.20

14.84

1.4

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1519

13114

1.41

14.75

7.5

5.7

77.00

78.05

u/l

0.49

1465

12207

(3004789) Transferrin [Mass/volume] in Serum or Plasma

308

1934

1.68

14.72

2.7

2.0

2.44

2.35

g/l

2.15

294

1777

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

160

3.36

14.65

1.6

1.2

—

(3026782) Osmolality of Urine

439

3011

1.56

14.58

3.0

2.4

530.14

559.77

mosm/kgh2o

2.04

387

2492

(3032080) INR in Blood by Coagulation assay

779

6001

1.44

14.55

8.9

6.6

1.23

1.21

inr

0.43

344

1718

(3024561) Albumin [Mass/volume] in Serum or Plasma

860

6752

1.42

14.42

4.9

3.8

35.34

36.33

g/l

6.31

809

6224

(40768806) Pleura Pathology biopsy report

7.74

14.42

1.2

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

288

1790

1.69

14.29

2.8

2.1

24.25

24.13

0.04

249

1557

(3001122) Ferritin [Mass/volume] in Serum or Plasma

959

7685

1.40

14.26

3.1

2.5

114.57

107.19

ug/l

0.32

911

7098

(1616796) Gas panel - Central venous blood

206

3.01

14.03

2.6

2.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

4.68

13.99

1.2

—

(40768797) Stomach Pathology biopsy report

324

2087

1.64

13.99

1.2

—

(3012441) Differential panel - Pleural fluid

7.46

13.97

1.2

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

213

1228

1.80

13.76

4.2

3.2

6.02

5.72

kpa

3.35

205

1199

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

376

2526

1.58

13.61

1.3

1.2

7.46

12.59

u/ml

1.27

206

1045

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

3.85

13.60

1.5

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

637

4790

1.44

13.35

3.3

2.8

68.74

115.30

e6/l

0.66

526

3535

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

618

4622

1.45

13.33

2.0

1.9

176.01

222.88

u/l

0.86

587

4322

(3028308) Erythrocytes [#/volume] in Pleural fluid

8.55

13.25

1.2

1.3

40696.67

16507.50

e6/l

—

(3026008) Bacteria identified in Urine by Culture

665

5049

1.43

13.20

3.0

2.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.94

13.13

1.5

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

172

3.13

13.06

1.6

1.5

0.62

0.81

g/l

1.02

134

(3026389) Candida sp identified in Specimen by Organism specific culture

188

3.02

13.03

1.5

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

340

2.46

12.73

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

387

2659

1.54

12.62

3.8

2.8

238.74

563.17

ng/l

1.32

235

1951

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

545

4043

1.45

12.12

2.3

2.0

3.06

2.85

mg/l

1.25

487

3392

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

674

5202

1.41

12.01

3.2

2.7

33.49

32.63

u/l

0.10

641

4951

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

4.23

11.98

1.1

1.0

4.74

17.04

iu/ml

1.71

(3002032) Base excess in Venous blood by calculation

206

1225

1.74

11.97

4.2

3.2

2.21

1.47

mmol/l

1.73

169

963

(3012544) pH of Venous blood

211

1271

1.72

11.71

4.2

3.2

—

7.38

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

351

2.35

11.44

1.8

1.7

0.79

3.72

ug/l

1.54

293

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.24

11.27

1.8

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

307

2053

1.57

11.24

3.3

2.7

0.82

mmol/l

0.19

284

1892

(3000850) Epithelial cells [#/volume] in Urine

445

3220

1.47

11.19

2.6

2.3

5.46

5.77

e6/l

0.25

388

2765

(44813793)

3.89

11.10

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.47

11.09

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1339

11607

1.34

11.03

4.6

3.9

191.62

2615.99

e6/l

2.59

150

(3000494) Fungus identified in Specimen by Culture

259

1675

1.61

10.92

1.4

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1034

8640

1.34

10.91

4.8

4.4

0.00

estimate

0.00

331

1535

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.12

10.87

1.5

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

447

3261

1.45

10.74

1.5

1.3

2.33

2.27

g/l

0.33

332

1938

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

4.74

10.70

1.1

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

4.74

10.70

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

4.74

10.70

1.1

1.2

—

(3022313) Gas panel - Capillary blood

107

534

2.05

10.69

3.9

3.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

1591

17490

0.74

10.51

16.3

10.7

40.68

39.70

6.28

1183

12829

(40767503) Oxygen content in Capillary blood by calculation

196

2.74

10.42

2.2

1.9

17.46

16.84

0.48

(3014111) Lactate [Moles/volume] in Serum or Plasma

175

1035

1.74

10.37

6.3

5.5

1.43

1.37

mmol/l

0.24

154

1001

(3022145) Colonoscopy Study observation

264

1737

1.58

10.35

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.30

10.29

1.8

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1039

8746

1.32

10.20

3.8

3.2

0.00

0.01

estimate

0.41

317

1505

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.70

10.18

1.6

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.70

10.18

1.6

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

313

2.34

10.14

1.3

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1583

14175

1.32

9.80

4.0

3.7

14.82

14.68

pmol/l

1.50

1474

12815

(3035350) Ketones [Presence] in Urine by Test strip

1024

8638

1.32

9.77

3.8

3.2

0.00

estimate

0.80

313

1515

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.89

9.59

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.89

9.59

1.1

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.89

9.59

1.1

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.89

9.59

1.1

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1981

18387

1.39

9.42

17.0

9.0

19.04

21.75

mg/l

3.88

1711

13482

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.70

9.29

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.70

9.29

1.1

1.83

6.68

u/ml

0.52

(3010421) pH of Blood

275

2.36

9.28

4.1

2.1

7.43

7.41

3.01

226

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

706

5680

1.34

9.28

3.3

2.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

340

2.21

9.18

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

220

1431

1.59

9.05

3.8

3.6

238.96

243.99

u/l

0.18

214

1341

(3011412) CD3 cells [#/volume] in Blood

3.36

9.03

1.6

2.3

1.10

1.14

e9/l

0.07

(3015171) Extractable nuclear Ab [Units/volume] in Serum

512

1.97

9.00

1.3

1.2

0.15

1.15

u/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

166

2.74

8.93

1.3

1.4

268.08

271.01

pmol/l

0.02

128

(3018095) Leukocytes [#/volume] in Urine

718

5827

1.33

8.80

4.0

3.1

83.61

114.52

e6/l

0.63

563

3859

(3003458) Phosphate [Moles/volume] in Serum or Plasma

256

1738

1.53

8.71

6.1

4.2

1.10

1.04

mmol/l

2.98

237

1606

(3024354) Oxygen [Partial pressure] in Venous blood

171

1058

1.66

8.61

4.5

2.9

4.99

4.54

kpa

1.02

164

1032

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

110

599

1.87

8.60

7.0

7.3

—

(3039000) Anion gap in Blood

242

2.39

8.51

4.6

5.1

11.10

11.21

mmol/l

0.08

212

(3018572) Chloride [Moles/volume] in Blood

243

2.38

8.44

4.6

5.1

103.81

105.87

mmol/l

2.70

213

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

5.18

8.40

1.3

1.0

—

(3047181) Lactate [Moles/volume] in Blood

354

2.12

8.33

5.0

4.2

1.22

mmol/l

0.00

299

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.37

8.14

1.5

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.65

8.00

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.49

7.81

1.6

2.1

11.43

15.05

0.73

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1340

11929

1.27

7.70

3.5

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

327

2.11

7.59

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

281

2.20

7.58

1.2

1.4

—

12.74

—

(3045424) Erythrocytes [Presence] in Urine

262

2.24

7.56

1.6

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

5.62

7.54

1.3

1.2

13.79

13.36

u/l

0.08

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

465

3622

1.35

7.37

1.7

1.6

63547244.27

36900794.08

pmol/l

0.36

406

2981

(3037467) Urinalysis macro (dipstick) panel - Urine

1365

12218

1.26

7.32

4.5

3.7

—

(3048689) Calprotectin [Mass/mass] in Stool

285

2047

1.44

7.31

2.3

127.00

125.16

ug/g

0.03

216

1606

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.62

7.29

1.6

1.4

—

0.80

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

+∞

7.29

1.6

0.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

161

2.57

7.26

1.3

1.6

—

(3045788) Cell count panel - Pleural fluid

5.41

7.24

1.4

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

267

2.20

7.23

3.3

2.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

122

2.81

7.16

1.6

1.4

29.04

26.64

0.11

(3015377) Calcium [Moles/volume] in Serum or Plasma

670

5514

1.29

7.16

3.0

2.8

2.35

2.36

mmol/l

1.39

601

4800

(3012501) Base excess in Blood by calculation

230

2.29

7.14

4.5

2.2

2.41

2.08

mmol/l

0.40

125

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

817

6911

1.27

6.98

6.4

4.4

1.21

1.22

mmol/l

1.08

754

6178

(3025941) Bacteria identified in Stool by Culture

138

854

1.65

6.98

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

165

2.51

6.92

1.4

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

7.17

6.69

1.8

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

154

990

1.59

6.69

2.1

67.00

67.41

g/l

0.32

141

871

(3020779) Urea [Moles/volume] in Serum or Plasma

163

1062

1.57

6.69

7.6

5.1

9.69

8.76

mmol/l

0.97

157

1007

(3006184) Hemoglobin [Mass/volume] in Capillary blood

250

2.19

6.67

1.7

1.9

135.23

131.19

g/l

0.35

192

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

206

2.31

6.61

1.2

1.1

14.08

10.43

au/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.31

6.41

1.2

1.3

4.95

6.33

u/l

0.82

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

5.47

6.28

1.0

—

(3003338) MCHC [Mass/volume]

1518

16414

0.80

6.26

19.4

12.8

331.78

332.84

g/l

4.30

1504

16267

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.02

6.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.02

6.22

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.02

6.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

5.02

6.22

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

126

788

1.63

6.15

1.4

21.94

26.78

iu/l

1.07

110

659

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1836

17171

1.27

6.09

14.9

9.4

83.80

82.71

ml/min/173m2

1.27

1607

13666

(40760888) Immunoglobulin light chains.free panel - Serum

247

2.13

6.06

1.7

2.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.24

6.00

2.0

1.4

—

(3044889) 12 lead EKG panel

1353

12251

1.23

5.96

3.8

3.2

—

(44790047)

3.00

5.95

1.6

1.1

—

(44790049)

3.00

5.95

1.6

1.1

—

(44806118)

3.00

5.95

1.6

1.1

—

(44790048)

3.00

5.95

1.6

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

141

2.50

5.94

3.3

2.6

0.77

0.81

nmol/l

0.18

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

552

1.73

5.83

7.5

7.6

24.25

23.71

mmol/l

0.96

516

(3004588) Protein electrophoresis panel - Serum or Plasma

134

864

1.58

5.79

1.6

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

194

1358

1.46

5.72

2.5

2.2

0.21

0.22

g/l

0.77

183

1263

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

209

2.17

5.57

1.1

1.2

39.67

23.51

u/l

0.81

182

(3030467) Casts [#/volume] in Urine by Automated count

530

4354

1.28

5.57

3.1

2.7

0.56

0.39

e6/l

0.80

420

3199

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

159

2.35

5.49

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

327

1.92

5.46

3.7

2.7

0.36

u/ml

0.06

173

(3018418) pH of Serum or Plasma

536

4419

1.27

5.46

4.6

3.1

7.39

7.40

0.96

145

800

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.35

5.44

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

247

2.04

5.30

1.3

1.4

7.04

7.06

mmol/l

0.01

167

(3017446) Testosterone [Moles/volume] in Serum or Plasma

165

1137

1.48

5.28

2.3

2.0

11.73

11.92

nmol/l

0.10

139

1010

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.02

5.26

1.3

2.6

—

(3000034) Microalbumin [Mass/volume] in Urine

133

2.42

5.13

3.2

2.8

49.90

13.17

mg/l

0.51

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.73

5.10

1.9

3.75

2.55

u/field

0.17

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

351

1.84

5.03

1.9

2.3

2.90

1.79

ratio

0.36

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

206

2.11

4.96

5.7

3.8

160.75

560.68

iu/ml

—

(3020891) Body temperature

495

1.70

4.92

4.8

3.8

—

(40758558) Short blood count panel - Blood

481

3964

1.26

4.87

7.6

5.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.59

4.76

2.9

1.6

524.80

1490.95

u/ml

1.00

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

395

1.77

4.74

2.1

2.0

816.26

1176.88

ug/l

0.17

372

(3018677) aPTT in Platelet poor plasma by Coagulation assay

280

2158

1.34

4.70

2.3

1.8

29.41

29.36

0.06

274

2096

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1280

11694

1.20

4.60

3.1

2.7

48.01

40.99

u/l

2.55

1218

10937

(3048929) Epstein Barr virus Ab [Presence] in Serum

445

1.71

4.56

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

155

2164

0.70

4.54

6.7

5.7

—

(3000060) B lymphocytes [#/volume] in Blood

3.84

4.53

1.9

2.1

442.86

218.57

e6/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.28

4.46

1.4

1.8

123.55

222.09

umol/l

0.67

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

418

1.72

4.44

1.6

0.29

0.14

iu/ml

0.37

(40768804) Tissue Pathology biopsy report

800

7021

1.21

4.41

2.1

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.83

4.38

1.4

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

474

3945

1.25

4.38

1.2

1.3

1.99

1.83

u/ml

0.09

173

1038

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

398

1.73

4.35

1.8

1.7

—

(36304419) Bacteria [Presence] in Urine

508

4265

1.24

4.33

3.1

2.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

177

2.11

4.32

3.7

3.5

3.57

1.40

0.79

134

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

632

1.57

4.31

5.7

3.7

24.12

23.63

mmol/l

0.67

571

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

362

1.76

4.30

1.9

2.3

29.82

65.77

mg/l

1.04

302

(3035880) pH of Pleural fluid

8.91

4.28

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

158

2.17

4.27

1.8

1.6

63.61

62.73

0.04

101

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.88

4.25

1.8

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

364

1.75

4.23

1.9

2.3

63.21

41.61

mg/l

0.70

298

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

359

1.75

4.14

1.6

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

137

960

1.45

4.09

3.0

3.4

4.38

4.53

pmol/l

1.39

129

842

(3013512) EKG study

551

4710

1.22

3.93

4.1

3.3

—

(3022689) Creatine [Moles/volume] in Urine

3.14

3.92

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

298

1.79

3.92

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

291

1.80

3.91

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1979

18938

1.23

3.90

17.6

11.1

3.96

mmol/l

0.03

1948

18294

(3019977) pH of Arterial blood

3.27

3.90

2.2

1.8

7.38

7.42

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

491

1.61

3.83

1.9

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

491

1.61

3.83

1.9

1.6

7.27

7.36

g/l

0.16

361

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

491

1.61

3.83

1.9

1.6

3.70

3.93

g/l

0.54

340

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.61

3.80

1.1

1.2

1.12

7.33

nmol/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

306

2459

1.28

3.79

3.3

2.5

4.41

2.54

e6/l

1.75

199

1319

(3008536) Aspergillus sp Ab [Presence] in Serum

12.02

3.76

1.5

2.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1971

18879

1.22

3.71

17.4

11.0

139.52

139.78

mmol/l

4.52

1941

18277

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

161

2.06

3.71

1.3

—

nmol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

116

2.25

3.64

1.3

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

147

1068

1.40

3.63

3.8

3.2

92.45

78.27

ng/l

0.94

123

927

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.87

3.62

2.2

2.3

81.06

100.06

1.74

(3008037) Lactate [Moles/volume] in Venous blood

340

1.69

3.48

2.3

2.4

1.44

1.59

mmol/l

0.67

329

(1002224) Polysomnography panel

601

1.52

3.45

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

450

3821

1.22

3.40

1.5

1.4

20.80

21.00

nmol/l

0.10

408

3242

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

282

1.75

3.40

1.1

1.2

—

0.62

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

1.58

3.37

1.9

1.6

2.88

3.05

g/l

0.67

355

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

154

2.03

3.35

2.7

3.6

17.00

41.16

u/ml

1.60

154

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

132

1792

0.72

3.32

1.5

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

337

1.68

3.32

1.3

1.6

312.02

11132.41

e6/l

0.51

279

(3034274) Bile acid [Moles/volume] in Serum --fasting

255

1.78

3.29

1.8

2.2

5.52

8.80

umol/l

0.70

185

(3002385) Erythrocyte distribution width [Ratio]

1654

15663

1.17

3.27

20.2

12.0

13.84

13.50

12.98

1631

15244

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

163

1.98

3.24

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

384

3227

1.22

3.21

1.7

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

171

1.94

3.19

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.32

3.17

1.0

1.1

1.43

0.44

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

2.32

3.17

1.0

0.69

0.33

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

590

1.49

3.13

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.24

3.05

1.3

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

417

3552

1.21

3.05

1.8

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.44

3.04

1.2

2.1

675.17

706.33

e6/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

671

0.57

3.04

1.2

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

377

1.61

3.04

5.3

4.3

1.49

1.29

mg/l

1.28

347

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

270

1.72

3.01

1.7

1.3

—

(4027681)

2.31

3.00

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.01

2.97

2.3

3.2

—

(3009508) Creatinine [Moles/volume] in Urine

587

5169

1.18

2.95

2.9

3.0

7.76

7.53

mmol/l

0.55

522

4370

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

420

1.56

2.94

2.0

1.8

0.48

0.78

g/l

0.47

357

(3003327) Ova and parasites identified in Stool by Light microscopy

517

1.50

2.93

1.4

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1785

17071

1.16

2.86

4.8

4.4

1.91

2.09

mu/l

0.70

1683

15572

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

337

1.62

2.83

1.2

1.5

31.31

20.19

e6/l

0.24

260

(21494755) Public health laboratory ask at order entry panel

230

1859

1.26

2.76

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

614

0.58

2.75

1.7

1.6

—

(3000991) Gas panel - Venous blood

138

1046

1.34

2.69

7.3

6.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

351

2979

1.21

2.67

3.1

2.7

2.46

2.45

mmol/l

1.18

309

2610

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

245

2004

1.25

2.66

1.7

1.52

1.38

1.92

218

1792

(3040151) Glucose [Moles/volume] in Capillary blood

147

1.91

2.65

4.2

3.6

7.84

6.68

mmol/l

0.39

123

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1203

0.70

2.64

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

490

1.48

2.60

1.6

1.4

8.85

8.68

u/l

0.05

399

(3007566) Smooth muscle Ab [Titer] in Serum

401

1.53

2.59

1.1

1.2

53.33

71.52

titre

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

1666

1.26

2.59

3.2

2.4

8.66

8.74

umol/l

0.02

179

1431

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

100

2.11

2.58

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

908

8329

1.14

2.58

4.2

3.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.01

2.56

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

379

1.54

2.54

1.3

1.4

485.36

501.78

mg/l

0.09

357

(3045414) Leukocytes [Presence] in Urine

104

763

1.38

2.51

1.9

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

166

2090

0.78

2.51

4.3

32.20

32.76

0.25

113

1374

(3042733) HLA Ab [Presence] in Serum

3.47

2.48

4.3

4.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

328

1.57

2.41

1.2

1.4

3.59

3.65

mmol/l

0.17

308

(3017143) Hepatitis C virus Ab [Presence] in Serum

234

1927

1.24

2.41

1.6

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

139

1075

1.31

2.39

2.2

2.3

41.63

20.56

au/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.05

2.31

1.4

—

(3024932) HLA-DR beta [Type]

3.11

2.22

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

504

0.59

2.22

1.4

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1726

16589

1.13

2.16

5.6

5.1

39.68

38.89

mmol/mol

3.40

1645

15306

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.29

2.15

1.7

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

4.29

2.15

2.5

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.29

2.15

1.7

1.0

95.67

92.79

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

267

2257

1.20

2.14

2.1

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

555

1.40

2.11

1.4

1.7

1.59

1.50

g/l

0.37

466

(3038515) Glucose [Moles/volume] in Venous blood

324

1.52

2.09

2.4

7.06

7.67

mmol/l

1.01

315

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

153

1.77

2.08

1.8

2.1

1.10

1.84

u/field

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

456

1.44

2.07

2.0

1.6

9.99

10.32

g/l

0.25

381

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.07

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

221

1842

1.22

2.06

1.5

1.3

—

(3005570) Glucose [Moles/volume] in Urine

184

1.69

2.04

2.3

1.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

619

1.37

2.03

4.6

2.6

1.47

1.20

0.98

609

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.05

2.01

1.1

1.0

1.07

1.17

u/l

—

(40768443) Skin Pathology biopsy report

681

1.35

2.00

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

256

1.57

1.98

1.7

1.3

103.75

106.59

u/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

549

4948

1.14

1.97

3.5

3.9

7.35

6.68

mg/mmol

0.15

382

3023

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

143

1142

1.27

1.97

2.1

2.0

4.20

7.00

ug/l

3.29

127

987

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

225

1.61

1.96

1.8

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

3.34

1.96

1.6

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.34

1.96

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

112

867

1.31

1.96

1.1

138.33

171.88

titre

—

(3037756) Immunofixation for Serum or Plasma

234

1.59

1.93

1.3

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

142

1.77

1.92

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

331

1.49

1.91

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

227

1.59

1.90

1.2

1.3

21.11

22.87

u/l

0.14

195

(3000570) Elastase.pancreatic [Mass/mass] in Stool

398

1.44

1.89

1.5

1.4

326.62

290.59

ug/g

0.82

212

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

365

1.46

1.89

2.1

2.3

116.53

83.14

ug/min

0.27

214

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.19

1.88

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.19

1.88

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.19

1.88

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

690

1.33

1.86

2.1

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

748

6902

1.12

1.82

1.9

96.46

96.53

pmol/l

0.01

418

3519

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

115

1.83

1.82

1.3

1.6

—

(40757373) Influenza virus identified in Isolate

4.17

1.82

1.6

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

693

1.32

1.81

1.6

286.48

297.37

mu/l

0.14

627

(3024471) HLA-A [Type]

2.76

1.79

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

216

1.58

1.76

1.1

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.03

1.74

2.9

2.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.34

1.74

1.0

—

(3036489) Thrombin time

524

1.36

1.74

3.0

1.9

21.28

21.04

0.12

446

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

189

1584

1.21

1.70

3.2

3.8

5.19

44.62

ug/l

1.16

164

1274

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.96

1.69

1.4

—

93.33

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

359

4038

0.87

1.68

3.7

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

288

2508

1.17

1.68

2.2

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

211

1.57

1.68

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.80

1.65

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

402

1.40

1.63

1.6

1.3

—

(3003181) Sodium [Moles/volume] in Urine

205

1.57

1.62

1.3

66.60

65.80

mmol/l

0.04

169

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.58

1.61

1.4

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

336

1.44

1.61

1.6

8337.82

13394.07

e6/l

0.72

243

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

238

1.52

1.59

1.2

1.3

5.58

5.31

u/ml

0.02

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.91

1.59

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.00

1.58

1.7

1.3

—

(44806071)

3.00

1.58

1.2

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.70

1.58

2.9

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.70

1.58

2.9

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.70

1.58

1.0

—

(3012516) Albumin [Mass/volume] in Urine

513

4672

1.12

1.56

2.8

3.1

416.82

237.36

mg/l

0.38

338

2806

(3027945) Reticulocytes/100 erythrocytes in Blood

187

1581

1.20

1.56

2.8

2.3

1.81

1.68

0.97

172

1378

(3006270) Folate [Moles/volume] in Blood

158

0.44

1.54

1.1

379.86

349.83

nmol/l

—

137

(3023520) Reticulocytes [#/volume] in Blood

142

1170

1.23

1.54

2.2

2.4

74.02

66.07

e9/l

1.83

117

867

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

224

1.52

1.54

1.2

1.3

3.09

3.78

u/ml

0.33

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.34

1.52

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.34

1.52

39.4

6.7

5.12

6.19

mmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.87

1.50

1.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

131

1074

1.23

1.49

2.5

2.6

4.45

3.84

e9/l

2.31

107

841

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

234

1.50

1.49

3.1

3.8

58.34

56.70

0.39

234

(3004616) Nuclear Ab [Presence] in Serum

162

1.61

1.49

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

146

1213

1.22

1.47

1.2

123.55

143.59

iu/ml

0.26

460

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

102

1.77

1.44

1.1

1.2

1.09

1.04

ratio

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

361

1.39

1.44

1.2

2.72

6.30

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.31

1.43

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

221

1.50

1.41

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

111

1.72

1.39

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.08

1.38

7.5

2.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

305

1.42

1.38

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.80

1.37

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.20

1.37

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

104

1.74

1.36

1.3

24.37

475.75

pmol/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.83

1.35

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.83

1.35

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.83

1.35

1.1

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.15

1.33

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

322

2880

1.14

1.33

1.6

1.7

1269.19

1149.46

nmol/l

1.41

254

2157

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.97

1.32

1.2

1.1

—

(40761535) Cells panel - Urine sediment

109

1326

0.81

1.32

3.7

3.0

—

(3049717) Cytology report of Urine Cyto stain

587

1.29

1.30

3.7

2.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

447

1.33

1.29

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

144

1213

1.20

1.29

1.3

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.89

1.28

1.1

1.0

138.77

223.16

iu/ml

1.01

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.89

1.28

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

448

0.69

1.27

1.6

1.5

64.62

142.13

pmol/l

1.42

438

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.09

1.27

2.1

7.33

9.28

mg/l

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.00

1.27

2.4

2.6

38.60

36.84

—

(3034426) Prothrombin time (PT)

2.05

1.26

1.4

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

107

1.69

1.25

2.2

1.4

18.17

22.43

u/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

450

1.32

1.24

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

245

1.43

1.23

1.1

2.36

3.61

u/ml

0.31

112

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.04

1.22

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

443

1.32

1.21

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

392

1.33

1.19

2.3

1.6

39.39

38.36

g/l

0.61

321

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.31

1.18

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

423

3873

1.11

1.18

3.9

3.5

1.02

kg/l

0.68

570

(3027944) Amphetamines [Presence] in Urine

805

1.23

1.15

2.2

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

126

1.59

1.14

1.2

1.1

55.50

61.20

u/l

0.19

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

150

1.54

1.14

1.1

1.2

—

(4281824)

184

0.54

1.13

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.34

1.12

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

—

(4035726)

155

1335

1.17

1.11

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

2.26

1.10

1.1

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

101

1211

0.83

1.10

1.4

1.5

—

(3024263) Appearance of Synovial fluid

1.76

1.06

1.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.12

1.05

1.0

1.2

111.29

100.04

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

1.60

1.05

1.1

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

178

1.47

1.05

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

825

1.21

1.04

2.2

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

564

0.76

1.02

1.5

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

818

1.21

1.01

2.2

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

134

1154

1.17

0.98

1.2

—

(40768795) Lymph node Pathology biopsy report

157

0.57

0.98

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.18

0.98

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

823

1.20

0.96

2.1

1.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.80

0.96

1.8

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

108

1.58

0.96

2.2

3.4

62.82

53.56

0.56

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

108

1.58

0.96

2.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

432

4646

0.91

0.95

1.5

1.6

1.47

1.31

mmol/l

3.21

380

3909

(3050129) First trimester maternal screen panel - Serum or Plasma

778

0.80

0.94

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

119

0.50

0.93

1.0

545.50

358.90

ng/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.22

0.93

1.5

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

120

0.50

0.93

1.0

71.83

49.15

ng/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

143

0.56

0.93

1.0

—

(40768800) Prostate Pathology biopsy report

339

0.70

0.93

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

175

1.43

0.92

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

754

1.20

0.92

2.0

1.9

—

(3028433) Virus identified in Specimen by Culture

2.07

0.89

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

113

971

1.17

0.87

1.4

—

(3014271) Vancomycin [Susceptibility]

1.79

0.87

2.7

2.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

272

1.33

0.87

1.4

1.2

216.13

229.99

u/ml

0.17

148

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.00

0.87

1.2

1.1

99.15

36.44

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

290

1.31

0.86

1.4

1.2

—

(3003694) ABO and Rh group [Type] in Blood

521

5535

0.93

0.86

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.82

0.85

1.0

1.2

—

(40761511) CBC panel - Blood by Automated count

2000

19684

1.08

0.84

15.3

9.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

163

1449

1.13

0.81

1.9

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.70

0.80

1.4

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

198

1.37

0.80

1.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.82

0.79

3.8

2.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.79

0.0

2.0

—

169.89

—

(3004451) EKG impression Narrative

1.67

0.78

1.5

1.1

—

(4306422)

234

1.33

0.77

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method

557

1.21

0.77

2.9

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.77

0.76

1.3

2.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

115

1004

1.15

0.75

1.8

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.08

0.74

1.6

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.08

0.74

1.0

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

414

1.24

0.74

1.9

2.33

4.96

iu/l

2.92

162

(3044640) Blood type and Crossmatch panel - Blood

558

5289

1.07

0.73

2.8

2.0

—

(40768446) Kidney Pathology biopsy report

1.80

0.72

1.3

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

785

1.16

0.71

2.6

2.0

3302.88

6330.58

u/l

0.87

329

(3024522) Salmonella sp identified in Specimen by Organism specific culture

177

1.36

0.70

1.2

1.3

—

(40768441) Liver Pathology biopsy report

118

1.44

0.69

1.3

—

(4133840)

1.67

0.68

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

119

0.59

0.67

1.0

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

142

1270

1.12

0.67

2.7

2.2

70.46

69.55

ml/min/173m2

0.10

498

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.63

0.66

1.7

1.1

59.90

63.24

—

(3011436) Histone Ab [Units/volume] in Serum

1.79

0.66

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

154

1.37

0.65

1.4

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

492

0.81

0.64

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

269

1.27

0.63

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

502

0.81

0.63

1.3

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

297

1.25

0.62

1.1

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

674

1.16

0.62

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.63

0.62

1.8

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

173

1.33

0.61

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.67

0.61

1.2

—

(3005033) Fetal Nuchal fold Thickness US

489

0.81

0.61

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

1.60

0.61

1.4

1.3

—

(3008898) HLA-B27 [Presence]

573

1.17

0.61

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

175

1.32

0.58

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

175

1.32

0.58

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

176

1611

1.10

0.57

3.4

2.6

—

(40768793) Breast Pathology biopsy report

418

0.81

0.56

1.2

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

329

1.22

0.56

3.4

2.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.62

0.55

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.54

0.55

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.54

0.55

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.45

0.55

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.45

0.55

1.2

1.1

—

(3002256) Pathology report gross observation

213

2297

0.92

0.55

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

315

2961

1.07

0.55

1.6

—

(3000012) Reticulocyte production index

1.47

0.54

1.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

599

0.85

0.53

1.3

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.52

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

598

0.85

0.52

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

214

1.26

0.52

1.5

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.62

0.52

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.50

0.51

1.0

1.1

—

(21494434) Karyotype in Bone marrow

126

1.35

0.51

1.8

1.2

—

(1761868) Lipid panel - Serum or Plasma

697

6726

1.05

0.51

2.4

2.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

596

0.85

0.51

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

596

0.85

0.51

1.3

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

128

1163

1.11

0.50

1.7

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

1.36

0.50

5.2

3.3

—

(3051651) Icteric interference index of Serum or Plasma

1.49

0.49

3.4

3.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

252

1.23

0.49

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

207

1.26

0.49

2.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

344

1.19

0.49

1.4

2.1

0.86

0.71

nmol/l

0.74

291

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.45

0.48

1.4

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

300

0.80

0.48

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

135

1472

0.91

0.47

4.5

3.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

637

1.13

0.45

2.7

1.9

—

(3036603) Volume of Urine

1.43

0.45

1.4

1.5

1819.60

1788.00

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

219

2050

1.07

0.45

1.9

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.40

0.45

1.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.40

0.45

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

556

0.86

0.45

2.3

3.1

53.90

880.60

u/ml

1.38

466

(3039443) Prostate specific Ag panel - Serum or Plasma

275

0.80

0.44

1.7

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.41

0.43

1.7

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.43

0.42

1.1

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

122

1.31

0.42

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.3

—

(3037121) Protein [Mass/volume] in Urine

520

1.14

0.41

4.3

2.9

0.23

g/l

0.01

199

(3017509) Phencyclidine [Presence] in Urine

0.00

0.40

0.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

275

2896

0.94

0.40

2.9

3.1

0.72

0.84

ug/l

1.26

162

1948

(3051101) Glucose [Moles/volume] in Cord blood

1.47

0.40

5.6

6.4

—

(3026470) Cobalt [Mass/volume] in Blood

104

0.67

0.39

1.4

2.0

0.60

3.18

ug/l

—

(3044927) Protein electrophoresis panel - Urine

124

1.29

0.38

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

1.39

0.38

2.6

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

224

1.21

0.38

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.34

0.38

1.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.33

0.37

1.2

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.29

0.36

1.0

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1760

17404

1.04

0.36

3.7

3.6

1.33

1.24

mmol/l

5.39

1658

15926

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.31

0.35

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.62

0.35

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

117

1.28

0.35

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

135

1.26

0.35

1.5

1.4

—

32.60

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.40

0.35

1.3

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2013

19964

1.04

0.34

10.4

8.1

28.44

25.17

u/l

2.26

1972

19129

(3000963) Hemoglobin [Mass/volume] in Blood

2127

21399

0.95

0.34

23.1

14.8

135.54

135.50

g/l

0.04

2114

21032

(1761482) Bacteria [#/volume] in Urine by Culture

445

1.13

0.32

3.7

3.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.35

0.32

1.1

1.3

120.10

357.91

u/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.33

0.32

1.1

1505.45

1605.86

miu/ml

0.14

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.31

0.31

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.31

0.31

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.31

0.31

1.3

1.1

—

(4034850)

560

1.11

0.31

6.3

9.5

—

(3025130) Human papilloma virus identified in Specimen

262

0.84

0.31

1.5

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

2127

21389

0.96

0.31

22.9

14.7

4.52

4.51

e12/l

0.84

2100

20658

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.32

0.30

1.0

—

(3010813) Leukocytes [#/volume] in Blood

2128

21397

0.96

0.30

23.0

14.7

7.18

6.53

e9/l

19.89

2101

20662

(3024731) MCV [Entitic volume]

2127

21387

0.96

0.30

22.9

14.7

90.78

90.63

0.74

2111

21012

(3035941) MCH [Entitic mass]

2127

21386

0.96

0.30

22.8

14.6

30.12

30.23

2.06

2111

21011

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

287

1.15

0.30

1.0

1.1

1.64

1989.90

iu/ml

0.51

(3014051) Protein [Presence] in Urine by Test strip

410

1.12

0.29

2.4

2.0

—

(4024509)

167

1.20

0.28

1.7

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

317

1.14

0.28

1.4

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.28

0.28

1.3

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1802

17862

1.03

0.28

4.3

4.1

5.87

5.82

mmol/l

0.86

1699

16212

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

131

1.22

0.27

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

146

1383

1.06

0.26

2.5

2.2

30.50

76.92

u/l

0.74

123

1173

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

225

1.16

0.26

1.1

127.19

117.72

0.49

199

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

387

3984

0.97

0.25

4.2

4.5

20.55

22.15

1.20

161

2030

(3006653) Thiamine [Moles/volume] in Blood

1.20

0.25

1.0

1.1

152.66

130.26

nmol/l

—

(3007461) Platelets [#/volume] in Blood

2127

21367

0.96

0.24

23.0

14.7

264.07

250.97

e9/l

15.46

2101

20690

(3024928) Oxygen saturation in Venous blood

255

1.14

0.24

7.9

3.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

316

3262

0.96

0.24

1.5

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

406

3948

1.03

0.23

4.1

3.1

92.28

92.04

0.07

393

3843

(3048879) Bone marrow aspiration report

1.32

0.23

1.0

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

351

1.11

0.23

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

1.23

0.23

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.28

0.23

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.25

0.22

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

181

1.16

0.22

2.2

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

981

1.06

0.22

1.1

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

294

0.88

0.21

3.4

3.0

34.75

28.30

u/ml

0.18

283

(3009871) Measles virus Ab [Titer] in Serum

1.19

0.21

1.6

1.8

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

8.30

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

343.20

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

3.00

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

1.8

—

765.30

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.20

0.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.9

—

1.48

—

(3000330) Specific gravity of Urine by Test strip

889

1.06

0.19

3.6

3.2

—

(3020650) Glucose [Presence] in Urine

1.18

0.19

1.2

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

607

1.07

0.19

1.3

171.13

220.59

miu/ml

0.90

291

(3041806) Other cells [#/volume] in Blood by Manual count

109

1.19

0.18

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

724

0.94

0.18

1.5

1.4

3.28

2.57

mg/l

0.40

484

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

100

1.20

0.18

1.0

—

(3045142) Bone marrow Pathology biopsy report

166

1.15

0.18

1.7

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.17

0.17

1.7

2.1

—

(4094501)

406

1.08

0.17

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.13

0.17

1.6

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.13

0.17

3.3

3.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

224

1.12

0.17

2.5

2.4

3.98

1829.25

u/ml

0.75

208

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.75

0.17

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

215

1.12

0.16

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

264

1.10

0.15

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

264

1.10

0.15

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

286

0.91

0.15

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.11

0.15

1.0

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

408

0.93

0.14

3.1

2.9

—

(3015736) pH of Urine

671

6625

1.02

0.13

3.3

3.0

—

5.69

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

408

4011

1.02

0.13

2.5

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

843

0.96

0.11

2.4

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

488

4938

0.98

0.10

4.8

5.1

2.87

4.21

ug/l

0.76

447

4430

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

125

1.12

0.10

1.5

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.09

0.09

1.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.09

0.09

1.4

7.57

9.37

ug/l

—

(3015183) Erythrocyte sedimentation rate

1.15

0.09

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

145

1.10

0.09

1.3

1.8

—

(4268621)

155

1.10

0.09

2.5

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1809

18141

0.99

0.09

4.0

1.48

1.50

mmol/l

1.35

1720

16722

(3017704) Immunofixation for Urine

1.05

0.08

1.2

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.83

0.08

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.82

0.08

8.8

4.5

7.13

8.62

mg/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

146

1.10

0.08

1.0

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.77

0.08

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.14

0.08

1.4

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.03

0.07

1.6

2.0

—

184.12

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

174

0.92

0.07

3.1

1.8

37.40

26.64

mg/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

215

1.07

0.07

1.5

1.2

—

(4198724)

1.04

0.07

5.8

1.6

—

(3022621) pH of Urine by Test strip

119

1164

1.02

0.07

2.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.84

0.06

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

528

0.96

0.06

2.0

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

101

0.89

0.06

3.4

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1826

18295

0.99

0.06

4.1

4.0

4.64

4.71

mmol/l

2.02

1736

16955

(3019225) pH of Specimen

162

1594

1.02

0.06

3.3

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

217

2196

0.99

0.05

1.6

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

374

0.96

0.05

4.6

3.1

26.76

26.81

mg/l

0.00

228

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

1.07

0.05

1.9

2.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

262

2643

0.99

0.04

2.9

2.4

2.48

1.44

e6/l

0.34

154

1488

(3051611) Lipemic interference index of Serum or Plasma

150

0.93

0.04

3.2

3.0

—

(4146454)

170

0.94

0.04

2.4

2.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

637

1.02

0.03

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

159

0.94

0.03

1.3

1.5

—

(3011648) Oxygen content in Venous blood

102

1.08

0.03

15.4

4.4

10.55

10.93

0.09

102

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

500

0.98

0.02

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

640

1.02

0.02

1.4

1.5

—

(36660697) Celiac disease serology panel - Serum

139

1400

0.99

0.01

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

163

0.98

0.00

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

105

0.95

0.00

5.7

6.9

—

(3021788) Differential panel - Synovial fluid

239

1.00

0.00

1.5

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1861

18608

1.00

0.00

4.4

4.5

2.72

2.79

mmol/l

2.84

1759

17124

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

275

0.98

0.00

1.4

0.28

0.31

nmol/l

0.18

223

(3044941) Cell count panel - Synovial fluid

223

0.99

0.00

1.5

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.95

0.00

8.3

12.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.00

0.00

2.6

4.4

—

74.36

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

7.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

2.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.94

0.00

1.0

1.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.3

—

3.48

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.86

0.00

1.0

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.85

0.00

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_MIXED_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_MIXED_EXMORE	1.854 [1.7, 2.02]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.331

During the follow-up period (1.1.1998 — 31.12.2019), 2432 out of 11328 females with ASTHMA_MIXED_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_MIXED_EXMORE	1.806 [1.64, 1.98]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2457 out of 11523 males with ASTHMA_MIXED_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_MIXED_EXMORE.

N-year risk	Females	Males
1	0.163%	0.312%
5	1.025%	1.98%
10	2.663%	4.947%
15	5.052%	9.244%
20	9.006%	15.523%

Relationships between endpoints

↥

Index endpoint: ASTHMA_MIXED_EXMORE – Asthma mixed form (mode), excluding more controls

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Asthma mixed form (mode), excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints